Ignite Creation Date:
2024-05-06 @ 2:18 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04275518
Status:
RECRUITING
Last Update Posted:
2023-08-30
First Post:
2020-02-05
Brief Title:
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-05
First Submit QC Date:
February 18 2020
Study First Post Date:
2020-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2023-08-30
Last Update Post Date Type:
ACTUAL